Cargando…
Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019
BACKGROUND: Because of the loss of chloroquine (CQ) effectiveness, the Democratic Republic of Congo (DRC)’s malaria treatment policy replaced CQ by sulfadoxine–pyrimethamine (SP) as first-line treatment of uncomplicated malaria in 2003, which in turn was replaced by artemisinin-based combination the...
Autores principales: | Yobi, Doudou M., Kayiba, Nadine K., Mvumbi, Dieudonné M., Boreux, Raphael, Kabututu, Pius Z., Akilimali, Pierre Z., Situakibanza, Hippolyte N. T., De Mol, Patrick, Speybroeck, Niko, Mvumbi, Georges L., Hayette, Marie-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830975/ https://www.ncbi.nlm.nih.gov/pubmed/35144535 http://dx.doi.org/10.1186/s12879-022-07112-z |
Ejemplares similares
-
Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance
por: Yobi, Doudou M., et al.
Publicado: (2020) -
Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018–2019
por: Yobi, Doudou M., et al.
Publicado: (2021) -
The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC)
por: Yobi, Doudou Malekita, et al.
Publicado: (2020) -
Care-seeking behaviour and socio-economic burden associated with uncomplicated malaria in the Democratic Republic of Congo
por: Kayiba, Nadine Kalenda, et al.
Publicado: (2021) -
The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review
por: Kayiba, Nadine Kalenda, et al.
Publicado: (2023)